Compare DraftKings Inc (DKNG) vs Medtronic PLC (MDT) Price & Performance

DraftKings IncTrade

Medtronic PLCTrade

Price performance (Past 24H)

Key statistics

DraftKings Inc vs Medtronic PLC — how do they compare? DraftKings Inc trades at $25.31 (market cap $12.58B), while Medtronic PLC trades at $90.25 (market cap $116.07B). The key difference: Medtronic PLC is far larger — about 9.2× DraftKings Inc's market cap, and Medtronic PLC pays a 3.18% dividend while DraftKings Inc pays none. Which is the better fit depends on your goals.

	DKNG	MDT
Market Cap	$12.58B	$116.07B
Sector	Consumer Cyclical	Health
52-Week High	$48.23	$105.35
52-Week Low	$20.72	$73.75
Enterprise Value	$13.51B	$134.82B
Dividend Yield	—	3.18%

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DKNG

DraftKings faces decline as prediction markets outpace traditional sportsbooks, shares down 30% YTD.Seeking Alpha · 2 days agoBearish DraftKings Q2 misses earnings but shows strong growth in Predictions platform, stock remains a hold ahead of NFL season.24/7 Wall Street · 2 days agoNeutral DraftKings' prediction markets drive rapid growth, reshaping its national sports betting strategy.PYMNTS · 5 days agoBullish View details →

MDT

Intuitive Surgical stock trades 28% below target despite strong business and growth prospects.24/7 Wall Street · 4 days agoNeutral View details →

About DraftKings Inc

DraftKings Inc is a digital sports entertainment and gaming company. The company provides users with daily fantasy sports (DFS), sports betting, and iGaming opportunities and is also involved in the design & development of sports betting and casino gaming platform software for online and retail sportsbook and casino gaming products. It operates in two segments: Business-to-consumer(B2C) and Business-to-Business(B2B), of which the vast majority of its revenue comes from the B2C segment. Geographically, it derives most of its revenue from the United States.

About Medtronic PLC

One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.